JTE 7-31
JTE 7-31 selectively acts on peripheral cannabinoid receptors, minimizing central nervous system side effects. They exhibit potent immunomodulatory, anti-inflammatory and anti-allergic properties, as well as inhibitory effects on nephritis[1].
Product Specifications
CAS Number
194358-72-0
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/jte-7-31.html
Smiles
O=C1N(CC2=C1C=CC(OC)=C2NCCCCC)CCC3=CC=C(C=C3)O
Molecular Formula
C22H28N2O3
Molecular Weight
368.47
References & Citations
[1]Novel compounds and pharmaceutical use thereof. WO9729079 A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC941081-500 1x 500 µL
CD45RO (190-2F2.5), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040003-500 1x 500 µL
CD45RO (UCHL-1), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC940043-100 1x 100 µL
P21 / WAF1 (WA-1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details